Brought to you by 
Ritter nets $18.6mm in IPO
29 Mar 2021
Executive Summary
Gastrointestinal disease-focused Ritter Pharmaceuticals Inc. netted $18.6mm in its initial public offering of 4mm common shares at $5 each. The company originally planned to sell 1.82mm common shares between $10 and $12.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Technologies
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Technologies
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ritter nets $18.6mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice